03.2 / Industries / DDS
Drug delivery
Metered release from patches, microneedle arrays and depots, with the dose rate set by design rather than a motor.
The problem
Controlled release usually means a choice between a membrane that diffuses at whatever rate the chemistry allows and an active pump that adds a battery, electronics and a failure mode.
What we do
Gradient-coated channels move formulation at a rate fixed by the surface design. We help you set that rate, prove it on prototypes, and carry the design into a process your contract manufacturer can run.
Device types
- DDS-01
Transdermal patches
Channel arrays that move drug to the skin surface
- DDS-02
Microneedle arrays
Feeding formulation to the needle field
- DDS-03
Implantable depots
Long-duration release with no moving parts
- DDS-04
Ocular delivery
Small-volume metering in tight geometries
- DDS-05
Inhalation devices
Liquid management ahead of aerosolization
- DDS-06
Combination therapy
Two drugs, two rates, one device
Design constraints we plan for
- Viscous formulations
- Biocompatible substrates
- Shelf-life stability